UKTIS provides services to support the appropriate use of medicines in pregnancy and to advise on management after in utero exposure to potentially harmful substances.
UKTIS provide advice and information for NHS health professionals via a dedicated telephone line, where pregnancy related enquiries can be discussed.
UKTIS also produce full systematic evidence review documents on maternal and paternal exposures to drugs and chemicals which can be accessed by healthcare professionals via www.uktis.org. Please visit the site to register. Registration is free to NHS and NHS-affiliated departments, units and practices in the UK. Abstracts from our systematic reviews are freely available to the public via www.uktis.org.
UKTIS also provides free patient information leaflets on our BUMPs (‘best use of medicines in pregnancy’) website. This information for women and their families is based on the rigorous scientific material UKTIS produces for healthcare professionals. It can be accessed via www.medicinesinpregnany.org.
Research and surveillance
A key role of UKTIS is to conduct national surveillance, collecting pregnancy outcome data from women exposed to drugs and chemicals in pregnancy. This generates prospective data on the incidence of fetal complications. Such information is fundamental to expanding the limited available data on which to base an accurate individual risk assessment for a pregnant woman exposed to drugs and chemicals, and provide preconception advice for men and women exposed to drugs and chemicals. These data are included in UKTIS systematic evidence reviews and are also published in peer reviewed journals.
Further information can be obtained from our website, www.uktis.org
Women can register their pregnancy online by visiting MyBump Portal.